Non-members: Click here to review a complimentary excerpt from "Internal Thought Leader Management: Medical Affairs Resourcing and Spend Allocations"
The pharmaceutical industry is constantly changing, and to navigate this new landscape pharmaceutical leaders are focusing on establishing and maintaining deep relationships with thought leaders. Paramount to this effort is having in place internal policies and practices that are focused on effectively managing these critical relationships.
Best Practices, LLC conducted a benchmark study that addressed how the industry is adjusting its approach to organizing, staffing and managing thought leader relationships.
The study provides insights and benchmarks that illustrate how leading pharma and biotech companies organize and structure their Medical Affairs capabilities. In addition, the study examines resource levels for effective Medical Affairs organizations and identifies the critical requirements to create strong Medical Affairs capabilities.
This study will inform medical affairs leaders on current trends and practices on these issues.
Data in this study is presented in segments by company size and global vs. US only.
- Medical Affairs Structure and Leadership
- Medical Affairs Spend Allocation and Importance of Functions
- Medical Affairs Spend Ratios
- Medical Affairs Structure
- Challenges and Success Factors to Build Strong Medical Affairs Capabilities
- Importance and Spend Allocation for Medical Affairs
- Medical Affairs Spending Breakout
- Medical Affairs Resource Level Change
- Medical Affairs Outsourcing Levels
- Importance of Medical Affairs Functions
- Issues Affecting Change in Medical Affairs Importance
- Revenue Per Medical Affairs FTE
- Medical Affairs Spend Per In-Market Product
- Medical Affairs Spend Per Pipeline Product
- Medical Affairs Spend Per Medical Affairs FTE
- Labor Spend
SAMPLE KEY FINDING
1. Medical Education
- Spend Allocation: Field-Based Medical Teams has the largest share of spend and Medical Affairs participants think that this is an area that is getting much more important. However, we didn't see this type of alignment (importance perception and spend allocation) in three Medical Affairs functions:
2. Outcomes Research / Real World Data
3. Medical Communication & Publication
Thirty-one survey responses from Medical Affairs leaders at 27 biopharmaceutical companies. This report captures insights on Large , Mid-Size and Small companies segments as well as on companies from Global and US-only regions.